Innovations

Innovative Russia

Innovation: we wanted the best...

The need to develop innovative business is often discussed by the top officials of the country and the region. As a rule, they say that innovation is a ticket to the future. But in practice things are not as smooth as we would like.

03.09.2009

Innovative Russia

The main troubles of Russian innovations

Despite the desire of the state and the scientific community to calculate all the bumps and sharp turns of the "great innovation path", this path remains unpredictable.

02.09.2009

Innovative Russia

RVC CEO – about venture business

The peculiarities of the high-tech market, and, in particular, the use of venture business for financing, is that money is not really needed for it. Paradoxical as it sounds.

01.09.2009

Biotechnologies - into life

V. Khristenko on the Russian pharmaceutical industry, medicine and biotechnology

Transcript of the report of the Minister of Industry and Trade at the meeting of the Commission on Modernization and Technological Development of the Russian Economy under the President of the Russian Federation. Main topics: pharmaceutical industry, medicine, biotechnology.

01.09.2009

Biotechnologies - into life

The President is dissatisfied with the Russian pharmaceutical industry

Russian President Dmitry Medvedev held a meeting of the commission on modernization and technological development of the Russian economy. The development of the pharmaceutical industry, medical equipment, medical and information technologies has been ordered to strengthen and deepen.

01.09.2009

Biotechnologies - into life

Pharma 2020: problems and prospects

The authors of the Pharma 2020 strategy state that its main goal is to create conditions for the "transition to an innovative development model" of the Russian pharmaceutical industry, but at the same time they schematically designate both mechanisms and tools that ensure such a transition.

01.09.2009

Note to the businessman

Develop innovative medicines or promote existing ones?

With the onset of the economic downturn, the solution of this problem has become even more important for pharmaceutical companies, since it calls into question not only their financial success, but also their very physical existence.

31.08.2009

Innovative Russia

Venture investments in Russia: personal experience

Konstantin Fokin (despite and even despite) continues to engage in venture investments in high-tech companies.

27.08.2009

Note to the businessman

I'll buy a bankrupt pharmaceutical company. Bargaining is appropriate

Controlled by the senator from Tuva and the owner of the United Industrial Corporation Sergey Pugachev, OPK Biotech LLC acquired the American pharmaceutical company Biopure Corporation. The transaction amount is $4.9 million.

26.08.2009

Note to the businessman

Crisis and pharmaceutical production: slowing down underperformance

The first steps to stabilize the pharmaceutical market have already been taken: as a result of the efforts of pharmaceutical manufacturers, despite the crisis difficulties, the rate of decline in pharmaceutical production volumes observed since September 2008 has slowed down.

26.08.2009

Note to the businessman

Personalized medicine is the engine of progress

According to PricewaterhouseCoopers experts, a number of factors will contribute to the development of personalized medicine and increase the value of innovative diagnostic methods.

25.08.2009

Note to the businessman

Stem cells go to IPO: first-hand details

The projects of the Institute of Human Stem Cells are characterized by a quick return on investment, which will be visible in 1-2 years.

25.08.2009

Innovative Russia

Small entrepreneurs! Keep your pocket wider!

This was stated by the head of the Department of Support and Development of Small and Medium-sized Businesses in Moscow, Mikhail Vyshegorodtsev, during a meeting with entrepreneurs, which took place at the Central House of Entrepreneurs.

24.08.2009

Note to the businessman

The main problem of Russian science

The most important problem of Russian science now is not even low funding. The main problem is that our practical results are not in demand in our country either by the economy or by society.

22.07.2009

Note to the businessman

The tragedy of Russian pharmaceutical production: there is where, there is with whom, but with nothing…

The main problem of Russian pharmaceutical companies is not competition with Western colleagues, but inability to it. There are more than 600 different pharmaceutical companies operating in our country, but many of the drugs they produce are uncompetitive.

22.07.2009

Note to the businessman

Research institutes and universities were allowed to earn without the consent of the state

Yesterday, the Duma presented a draft Federal law "On Amendments to Certain Legislative Acts of the Russian Federation on the creation of economic societies by budgetary institutions of science and Education for the practical application (implementation) of the results of intellectual activity."

16.07.2009

Note to the businessman

Key indicators of Russian science in 2005-2007

Collection "Indicators of Science: 2009". The collection gives a very detailed picture of the state of Russian research and Development in recent years.

15.07.2009

Biotechnologies - into life

From Siberia with a vaccine

Vector-BiAlgam offers Russia's first combined vaccine against hepatitis A and B, plans to create a bottling site for injectable drugs and hopes to organize the production of immunoglobulins from donated blood.

15.07.2009

Biotechnologies - into life

"DNA Technology" is gaining momentum

Now DNA Technology has entered into cooperation with many Russian medical centers that work in the field of diagnostics, with blood transfusion stations, with cancer centers.

13.07.2009

Note to the businessman

MICEX will help innovative companies grow

The new MICEX sector is designed to bring, first of all, young high-tech companies to the market. High-tech companies, as well as those using bio- and nanotechnology, are prioritized.

10.07.2009